Sarcoidosis Overview Make an Appointment Find a Doctor Ask a Question Reviewed by Clara Restrepo, MD (October 01, 2018) Sarcoidosis is a chronic disease that can affect any organ in the body, but most commonly affects the lungs. Very small (microscopic) clusters of inflammation or white cells, called granulomas, are seen in the organs affected with sarcoidosis. These granulomas may clear up on their own, or may cause organ dysfunction and scarring. While there is no cure for sarcoidosis at this time, the disease can be managed to minimize organ dysfunction. Sarcoidosis Care at National Jewish Health National Jewish Health is recognized by the World Association for Sarcoidosis and Other Granulomatous Diseases (WASOG) as a WASOG Sarcoidosis Clinic. This designation provides formal recognition of our team’s commitment to meet the needs of sarcoidosis patients and success in keeping to keep abreast of the ongoing advances and findings. National Jewish Health is currently involved with ongoing research regarding sarcoidosis. Results of this research will be used to develop better diagnosis and treatment for people with sarcoidosis. Causes Sarcoidosis is likely to have more than one cause. Sarcoidosis is most common in young people between the ages of 20 and 40. However, it can affect any age group and race. About 10 to 40 of 100,000 people develop sarcoidosis. Sarcoidosis is not contagious. Programs & Services Division of Environmental & Occupational Health Sciences Respiratory Treatment Programs Sarcoidosis Program Clinical Trials For more than 100 years, National Jewish Health has been committed to finding new treatments and cures for diseases. Search our clinical trials. Immune Pathways & Development of Sarcoidosis We Are Open and Here for You × Our specialty care clinics for adults and children are open and ready to serve you. Your health is important, and that means taking care of your existing health care issues. To make an appointment, call 303.398.1355 or make an appointment online. Patient Safety As we schedule appointments, including necessary procedures, we're taking every precaution to ensure your safety. All staff and providers are required to wear masks and other personal protective equipment, and our facilities are continually cleaned using enhanced sterilization procedures. As best practice for all patients, COVID-19 patients are cared for in separate, dedicated units. Patients and visitors are screened upon arrival and are required to wear masks. Patients may have only one visitor accompany them to appointments. Please bring your own face mask to wear (cannot be a bandana or scarf, but can be a cloth mask). Expanded COVID-19 Testing and Care Available Testing and care for adults and children who may currently have or are recovering from COVID-19 is available. COVID-19 Testing, Care & Resources Close
Reviewed by Clara Restrepo, MD (October 01, 2018) Sarcoidosis is a chronic disease that can affect any organ in the body, but most commonly affects the lungs. Very small (microscopic) clusters of inflammation or white cells, called granulomas, are seen in the organs affected with sarcoidosis. These granulomas may clear up on their own, or may cause organ dysfunction and scarring. While there is no cure for sarcoidosis at this time, the disease can be managed to minimize organ dysfunction. Sarcoidosis Care at National Jewish Health National Jewish Health is recognized by the World Association for Sarcoidosis and Other Granulomatous Diseases (WASOG) as a WASOG Sarcoidosis Clinic. This designation provides formal recognition of our team’s commitment to meet the needs of sarcoidosis patients and success in keeping to keep abreast of the ongoing advances and findings. National Jewish Health is currently involved with ongoing research regarding sarcoidosis. Results of this research will be used to develop better diagnosis and treatment for people with sarcoidosis. Causes Sarcoidosis is likely to have more than one cause. Sarcoidosis is most common in young people between the ages of 20 and 40. However, it can affect any age group and race. About 10 to 40 of 100,000 people develop sarcoidosis. Sarcoidosis is not contagious.